ČLÁNEK
Sarkar A., Novohradský V., Maji M., Babu T., Marková L., Kostrhunová H., Kašpárková J., Gandin V., Brabec V., Gibson D.
Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION.
2023.
Chen F., Soldevila-Barreda J., Romero-Canelón I., Coverdale J., Song J., Clarkson G., Kašpárková J., Habtemariam A., Brabec V., Wolny J., Schünemann V., Sadler P.
Effect of sulfonamidoethylenediamine substituents in Ru-II arene anticancer catalysts on transfer hydrogenation of coenzyme NAD( ) by formate.
DALTON TRANSACTIONS.
2018.
Brabec V., Vrána O., Nováková O., Kašpárková J.
Comment on "Delivering a photosensitive transplatin prodrug to overcome cisplatin drug resistance'' by H. Song, W. Li, R. Qi, L. Yan, X. Jing, M. Zheng and H. Xiao, Chem. Commun., 2015, 51, 11493.
Chemical Communications.
2016.
Schmitt F., Donnelly K., Muenzer J., Rehm T., Novohradský V., Brabec V., Kašpárková J., Albrecht M., Schobert R., Mueller T.
Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and gold.
Journal of Inorganic Biochemistry.
2016.
Salem OM., Vilková M., Janočková J., Jendželovský R., Fedoročko P., Zilecká E., Kašpárková J., Brabec V., Imrich J., Kožurková M.
New spiro tria(thia)zolidine-acridines as topoisomerase inhibitors, DNA binders and cytostatic compounds.
International Journal of Biological Macromolecules.
2016.
Münzner JK., Rehm T., Biersack .., Casini A., de Graaf IAM., Worawutputtapong .., Noor .., Kempe R., Brabec V., Kašpárková J., Schobert R.
Adjusting the DNA interaction and anticancer activity of Pt(II) N-heterocyclic carbene complexes by steric shielding of the trans leaving group.
Journal of Medicinal Chemistry.
2015.
Janočková .., Plšíková J., Kašpárková J., Brabec V., Jendželovský R., Mikeš J., Koval J., Hamuľ áková S., Fedoročko P., Kuča K., Kožurková M.
Inhibition of DNA topoisomerases I and II and growth inhibition of HL-60 cells by novel acridine-based compounds.
European Journal of Pharmaceutical Sciences.
2015.
Zhao Y., Woods JA., Farrer NJ., Robinson KS., Prachařová J., Kašpárková J., Nováková O., Li H., Salassa L., Pizarro AM., Clarkson GJ., Song L., Brabec V., Sadler PJ.
Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts.
Chemistry: A European Journal.
2013.
Nováková O., Malina J., Kašpárková J., Halámiková A., Bernard V., Intini F., Natile G., Brabec V.
Energetics, conformation, and recognition of DNA duplexes modified by methylated analogues of [PtCl(dien)]+. Chem Eur J, 15, 6211-6221.
Chemistry: A European Journal.
2009.
Bugarcic T., Nováková O., Halámiková A., Zerzánková L., Vrána O., Kašpárková J., Habtemariam A., Pardone S., Sadler P., Brabec V.
Cytotoxicity, cellular uptake, and DNA interactions of new monodentate ruthenium(II) complexes containing terphenyl arenes.
Journal of Medicinal Chemistry.
2008.
Bugarcic T., Habtemariam A., Štěpánková J., Heringová P., Kašpárková J., Deeth J.R.., Johnstone R.D.L., Prescimone A.., Parsons S.., Parkin A.., Brabec V., Sadler P.
The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
Inorganic Chemistry.
2008.